Better Buy in the Obesity Drug Race: Novo Nordisk or Eli Lilly?

Source The Motley Fool

Key Points

  • Eli Lilly leads in next‑gen obesity drugs, while Novo Nordisk offers a cheaper, dividend‑paying alternative.

  • Novo’s steady insulin cash flows and new MASH bet could expand growth beyond its core diabetes focus.

  • 10 stocks we like better than Novo Nordisk ›

Discover how Novo Nordisk (NYSE: NVO) stacks up against Eli Lilly (NYSE: LLY) in the obesity and metabolic race, from GLP‑1 leadership to NASH/MASH optionality and dividend appeal. Watch the video below to see which profile fits your portfolio.

*This video was published on Jun. 26, 2026.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

Should you buy stock in Novo Nordisk right now?

Before you buy stock in Novo Nordisk, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $382,359!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,201,390!*

Now, it’s worth noting Stock Advisor’s total average return is 883% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of June 26, 2026.

Alicia Alfiere, MBA has no position in any of the stocks mentioned. Danny Vena, CPA has no position in any of the stocks mentioned. Karl Thiel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Eli Lilly and Novo Nordisk. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold Price Forecast: PCE Data Weakens Fed Rate Hike Expectations, Can Gold Price Hold Steady at $4,000?As of today's Asian session (June 26), gold ( XAUUSD) prices fluctuated near $4,010. Yesterday, gold rebounded following the release of the PCE data, and market sentiment improved signifi
Author  TradingKey
12 hours ago
As of today's Asian session (June 26), gold ( XAUUSD) prices fluctuated near $4,010. Yesterday, gold rebounded following the release of the PCE data, and market sentiment improved signifi
placeholder
Australian Dollar edges lower to near 0.6900 on Fed hike bets The AUD/USD pair edges lower to around 0.6900 during the Asian trading hours on Friday. The US Dollar (USD) strengthens against the Australian Dollar (AUD) on the expectation of US rate hikes later this year.
Author  FXStreet
21 hours ago
The AUD/USD pair edges lower to around 0.6900 during the Asian trading hours on Friday. The US Dollar (USD) strengthens against the Australian Dollar (AUD) on the expectation of US rate hikes later this year.
placeholder
Gold Price Forecast: Gold Price Falls Below $4,000, PCE Data May Push Gold Down to $3,900As of today (June 25) during the Asian session, gold ( XAUUSD) was last priced at $3,976.90, down 0.54% on the day. After gold prices fell below $4,000 yesterday, they fluctuated around $
Author  TradingKey
Yesterday 08: 52
As of today (June 25) during the Asian session, gold ( XAUUSD) was last priced at $3,976.90, down 0.54% on the day. After gold prices fell below $4,000 yesterday, they fluctuated around $
placeholder
Crypto market sheds over 50% of its value amid Bitcoin's brief decline below $60KThe crypto market has erased more than half of its value since reaching an all-time high in late 2025. The decline underscores the severity of the recent bear market and lack of a fresh catalyst to revive investor interest, according to a Wednesday X post by The Kobeissi Letter.
Author  FXStreet
Yesterday 01: 47
The crypto market has erased more than half of its value since reaching an all-time high in late 2025. The decline underscores the severity of the recent bear market and lack of a fresh catalyst to revive investor interest, according to a Wednesday X post by The Kobeissi Letter.
placeholder
Gold Price Trend Forecast: Gold Price Risks Falling Below $4,000, PCE Data Is Key As of the European session today (June 24), gold prices ( XAUUSD) remained weak and fell intraday, touching an intraday low of $4,050 to hit a near two-week low, signaling clear short-ter
Author  TradingKey
Jun 24, Wed
As of the European session today (June 24), gold prices ( XAUUSD) remained weak and fell intraday, touching an intraday low of $4,050 to hit a near two-week low, signaling clear short-ter
goTop
quote